Skip to main content
Premium Trial:

Request an Annual Quote

Gencove Raises $10M in Series A Financing

NEW YORK – Low-pass genome sequencing firm Gencove said on Tuesday that it has closed a $10 million Series A financing round.

Lewis & Clark AgriFood led the round, joined by new and existing investors, including Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures. In a statement, Gencove said the funding would be used for product development and commercial growth and to build key business functions.

"Gencove's platform and datasets can help unlock the genetic underpinnings of our health and well-being," Larry Page, managing director at Lewis & Clark AgriFood, said in a statement. "We are thrilled to be part of a company whose technology has such broad consumer and industrial applications from agrigenomics, biotechnology, virology to medical diagnoses, disease susceptibility, and response to medical treatment."

The New York-based firm, a spinout from the New York Genome Center, has now raised a total of $16.2 million, including $3 million in March 2019. It offers low-pass sequencing and analytics software as a service.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.